The Global Initiative for Chronic Obstructive Lung Disease (GOLD) published its first report
for the diagnosis and management of chronic obstructive pulmonary disease (COPD) in …

The pathology and impact of chronic obstructive pulmonary disease (COPD) results from an
abnormal inflammatory process resulting in tissue damage with ineffective repair in …

Background Eosinophilic airway inflammation in patients with chronic obstructive pulmonary
disease (COPD) is associated with exacerbations and responsivity to steroids, suggesting …

The impact of blood eosinophilia in chronic obstructive pulmonary disease (COPD) remains
controversial. To evaluate the prevalence and stability of a high level of blood eosinophils …

Background There is controversy regarding the role of blood eosinophil levels as a
biomarker of exacerbation risk in chronic obstructive pulmonary disease (COPD). Our aim …

Background: Asthma and COPD are complex, heterogeneous conditions comprising a wide
range of phenotypes, some of which are refractory to currently available treatments …

The hypoxic ventilatory response (HVR) is the increase in breathing in response to reduced
arterial oxygen pressure. Over several decades, studies have revealed substantial …

An individual's experience of COPD is determined by many factors in addition to the
pathological features of chronic bronchitis and emphysema and the symptoms that derive …

Information for Category 1 CME Credit Credit can now be obtained, free for a limited time, by
reading the review articles in this issue. Please note the following instructions. Method of …

Airway inflammation in chronic obstructive pulmonary disease (COPD) is typically thought to
be driven by Type1 immune responses, while Type2 inflammation appears to be present in …